Initial CIMAvax Results: Dr. Dy Shares Findings From Clinical Trial 

Dr. Grace Dy, Principal Investigator of the first North American clinical trial of CIMAvax-EGF, shares initial results from the study. Dr. Dy presented the findings on September 25, 2018, at the International Association for the Study of Lung Cancer’s 19th World Conference on Lung Cancer in Toronto. Learn more: goo.gl/VF6Tbp